Nouveau Life Pharmaceuticals

(OTC) NOUV

Current Price$0.00

Market Cap$6.70K

Since IPO (1998)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Nouveau Life Pharmaceuticals Financials at a Glance

Market Cap

$6.70K

Revenue (TTM)

$0.00

Net Income (TTM)

-$153.38K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

80.51 (High)

Dividend

$0.00

Beta (Volatility)

80.51 (High)

Price

$0.00

Volume

100,000

Open

$0.00

Price

$0.00

Volume

100,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

80.51 (High)

Price

$0.00

Volume

100,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

NOUV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nouveau Life Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

CEO

Sang Tae Choi

Website

www.nouv-info.com

Headquarters

Ft. Lauderdale, FL 33301, US

NOUV Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-3%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.70K

Shares Outstanding

6.66B

Volume

100.00K

Avg. Volume

299.53K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$17.21K

EBITDA

-$17.21K

Operating Cash Flow

-$22.91K

Capital Expenditure

$0.00

Free Cash Flow

-$22.91K

Cash & ST Invst.

$3.97K

Total Debt

$67.77K

Nouveau Life Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$6.70K

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$5.62K

+95.0%

EBITDA

-$5.62K

+92.1%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Total Cash

$7.71K

+94.5%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.29%

N/A

Return on Invested Capital

-3.14%

N/A

Free Cash Flow

$3.42K

+244.2%

Operating Cash Flow

$3.42K

+244.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MTEIMountain Energy Inc

MTEIMountain Energy Inc$0.00+0.00%

CGSICGS International, Inc.

CGSICGS International, Inc.$0.00+0.00%

OHCSOptimus Healthcare Services, Inc.

OHCSOptimus Healthcare Services, Inc.$0.00+0.00%

TKCITurnKey Capital, Inc.

TKCITurnKey Capital, Inc.$0.11-0.91%

IKTOiTokk, Inc.

IKTOiTokk, Inc.$0.00+0.00%

IFANIFAN Financial, Inc.

IFANIFAN Financial, Inc.$0.00+0.00%

AMLHAmerican Leisure Holdings, Inc.

AMLHAmerican Leisure Holdings, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$192.50+0.20%

PAYOPayoneer Global

PAYOPayoneer Global$7.03+0.04%

PATHUiPath

PATHUiPath$10.79+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.89+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.85+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$84.59+0.09%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.31-0.09%

Questions About NOUV

What is the current price of Nouveau Life Pharmaceuticals?

Nouveau Life Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Nouveau Life Pharmaceuticals?

Over the past 52 weeks, Nouveau Life Pharmaceuticals has traded between $0.00 and $0.00.

How much debt does Nouveau Life Pharmaceuticals have?

As of the most recent reporting period, Nouveau Life Pharmaceuticals reported total debt of $0.00.

How much cash does Nouveau Life Pharmaceuticals have on hand?

Nouveau Life Pharmaceuticals reported $3.52K in cash and cash equivalents in its most recent financial results.

What is Nouveau Life Pharmaceuticals’s dividend yield?

Nouveau Life Pharmaceuticals does not currently have a dividend yield.

Nouveau Life Pharmaceuticals

Nouveau Life Pharmaceuticals Financials at a Glance

NOUV News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nouveau Life Pharmaceuticals

NOUV Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nouveau Life Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NOUV

What is the current price of Nouveau Life Pharmaceuticals?

What is the 52-week range for Nouveau Life Pharmaceuticals?

How much debt does Nouveau Life Pharmaceuticals have?

How much cash does Nouveau Life Pharmaceuticals have on hand?

What is Nouveau Life Pharmaceuticals’s dividend yield?

Premium Investing Services